Fragment-Based Identification of Ligands for Bromodomain-Containing Factor 3 of Trypanosoma cruzi

ACS Infect Dis. 2021 Aug 13;7(8):2238-2249. doi: 10.1021/acsinfecdis.0c00618. Epub 2020 Nov 17.

Abstract

The Trypanosoma cruzi (T. cruzi) parasite is the cause of Chagas disease, a neglected disease endemic in South America. The life cycle of the T. cruzi parasite is complex and includes transitions between distinct life stages. This change in phenotype (without a change in genotype) could be controlled by epigenetic regulation, and might involve the bromodomain-containing factors 1-5 (TcBDF1-5). However, little is known about the function of the TcBDF1-5. Here we describe a fragment-based approach to identify ligands for T. cruzi bromodomain-containing factor 3 (TcBDF3). We expressed a soluble construct of TcBDF3 in E. coli, and used this to develop a range of biophysical assays for this protein. Fragment screening identified 12 compounds that bind to the TcBDF3 bromodomain. On the basis of this screen, we developed functional ligands containing a fluorescence or 19F reporter group, and a photo-crosslinking probe for TcBDF3. These tool compounds will be invaluable in future studies on the function of TcBDF3 and will provide insight into the biology of T. cruzi.

Keywords: BI-2536; Chagas disease; Trypanosoma cruzi; bromodomain-containing factor 3; fragment-based discovery.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chagas Disease*
  • Epigenesis, Genetic
  • Escherichia coli
  • Humans
  • Ligands
  • Trypanosoma cruzi* / genetics

Substances

  • Ligands